BioCentury
ARTICLE | Financial News

CytomX amends IPO

October 5, 2015 7:00 AM UTC

CytomX Therapeutics Inc., South San Francisco, Calif. Business: Antibodies, Cancer, Autoimmune Date announced: 2015-09-28 Type: IPO To be raised: Up to $106.7 million Shares: 6.7 million Price: $14-$1...